The transcription factor wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL

Medicine and Dentistry

• Acute Myeloid Leukemia 16%
• Acute Myeloid Leukemia Cell Line 8%
• Antiapoptotic 16%
• Aptitude 8%
• Bcl-xL 33%
• Cancer Cell 8%
• Cancer Therapy 8%
• Cells 16%
• Client 8%
• Combination Therapy 8%
• Development 8%
• down Regulation 8%
• Heat Shock Protein 90 16%
• Leukemia 8%
• Leukemia Cell 25%
• Malignant Neoplasm 8%
• Monotherapy 8%
• Myeloid Leukemia 25%
• Neoplasm 8%
• Patient 8%
• Programmed Cell Death 33%
• Promoter Region 8%
• Protein 8%
• Protein Bcl Xl 16%
• Short Hairpin RNA 16%
• Therapeutic Agent 16%
• Transcription Factor 8%
• Tumor Necrosis Factor Related Apoptosis Inducing Ligand 100%
• Wilms' Tumor 8%